3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Prostatic Neoplasms
7
Polycystic Ovary Syndrome
5
Ovarian Hyperstimulation Syndrome
3
Infertility
3
Breast Neoplasms
2
The Neoadjuvant Therapy
1
Sarcoma, Ewing
1
Sarcoma
1
Osteosarcoma
1
Neoplasms
1
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
1
Lymphoma
1
Helping Behavior
1
Interventions
Cyclophosphamide
3
seclidemstat
2
Topotecan
2
Drug Therapy
2
irinotecan sucrosofate
1
anlotinib
1
Vinorelbine
1
Vincristine
1
Triptorelin Pamoate
1
Trabectedin
1
Temozolomide
1
TQ-B3525
1
Microbiota
1
Metabolome
1
Irinotecan
1
IVA protocol
1
Biological Factors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Sarcoma, Ewing
×
Triptorelin Pamoate
×
Clear all
NCT02856048
2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3
Unknown
11 enrolled